CH447183A - Verfahren zur Herstellung von neuen Chinazolon-Verbindungen - Google Patents
Verfahren zur Herstellung von neuen Chinazolon-VerbindungenInfo
- Publication number
- CH447183A CH447183A CH90567A CH9056764A CH447183A CH 447183 A CH447183 A CH 447183A CH 90567 A CH90567 A CH 90567A CH 9056764 A CH9056764 A CH 9056764A CH 447183 A CH447183 A CH 447183A
- Authority
- CH
- Switzerland
- Prior art keywords
- new
- production
- quinazolone compounds
- quinazolone
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEF39784A DE1231705B (de) | 1963-05-18 | 1963-05-18 | Verfahren zur Herstellung von 2, 3-substituierten Chinazolon-(4)-derivaten |
DEF0042147 | 1964-02-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH447183A true CH447183A (de) | 1967-11-30 |
Family
ID=25975761
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH90567A CH447183A (de) | 1963-05-18 | 1964-05-14 | Verfahren zur Herstellung von neuen Chinazolon-Verbindungen |
CH628164A CH447181A (de) | 1963-05-18 | 1964-05-14 | Verfahren zur Herstellung von Chinazolon-Verbindungen |
CH90467A CH447182A (de) | 1963-05-18 | 1964-05-14 | Verfahren zur Herstellung von neuen Chinazolon-Derivaten |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH628164A CH447181A (de) | 1963-05-18 | 1964-05-14 | Verfahren zur Herstellung von Chinazolon-Verbindungen |
CH90467A CH447182A (de) | 1963-05-18 | 1964-05-14 | Verfahren zur Herstellung von neuen Chinazolon-Derivaten |
Country Status (10)
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1003802A (en) * | 1963-06-04 | 1965-09-08 | Searle & Co | Pyrimidinone derivatives |
GB1062357A (en) * | 1965-03-23 | 1967-03-22 | Pfizer & Co C | Quinazolone derivatives |
DE2027645A1 (de) * | 1970-06-05 | 1971-12-09 | Byk Gulden Lomberg Chemische Fa bnk GmbH, 7750 Konstanz | Piperazinylalkyl chinazolon (4) den vate, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel |
US3900476A (en) * | 1973-05-17 | 1975-08-19 | Upjohn Co | 2(2'-pyrimidylamino)quinazolines and their preparation |
US3936453A (en) * | 1974-01-28 | 1976-02-03 | Sandoz, Inc. | 1-Substituted-2-disubstituted aminoquin azolin-4(1h)-ones |
US3959279A (en) * | 1974-01-28 | 1976-05-25 | Sandoz, Inc. | 1-Substituted-2-imino-quinazolin-4(1H)ones |
US4113637A (en) * | 1974-09-10 | 1978-09-12 | Institut Francais Du Petrole | Alkyl-guanidino-heterocyclic compounds, their manufacture and use as additives for fuels and lubricants |
GB8429739D0 (en) * | 1984-11-24 | 1985-01-03 | Fbc Ltd | Fungicides |
US5756502A (en) * | 1994-08-08 | 1998-05-26 | Warner-Lambert Company | Quinazolinone derivatives as cholyecystokinin (CCK) ligands |
WO1997010221A1 (en) * | 1995-09-15 | 1997-03-20 | Torrey Pines Institute For Molecular Studies | Synthesis of quinazolinone libraries |
US6258819B1 (en) * | 1999-08-05 | 2001-07-10 | Syntex (U.S.A.) Llc | Substituted 2(4-piperidyl)-4(3H)-quinazolinones and 2-(4-piperidyl)-4(3H)-azaquinazolinones |
US6545004B1 (en) | 1999-10-27 | 2003-04-08 | Cytokinetics, Inc. | Methods and compositions utilizing quinazolinones |
US7230000B1 (en) | 1999-10-27 | 2007-06-12 | Cytokinetics, Incorporated | Methods and compositions utilizing quinazolinones |
US7671200B2 (en) * | 1999-10-27 | 2010-03-02 | Cytokinetics, Inc. | Quinazolinone KSP inhibitors |
SI2223922T1 (sl) * | 2000-04-25 | 2016-04-29 | Icos Corporation | Inhibitorji humane fosfatidil-inositol 3-kinazne delta izoforme |
US6667300B2 (en) * | 2000-04-25 | 2003-12-23 | Icos Corporation | Inhibitors of human phosphatidylinositol 3-kinase delta |
WO2002094790A1 (fr) * | 2001-05-23 | 2002-11-28 | Mitsubishi Pharma Corporation | Compose heterocyclique condense et son utilisation medicale |
CA2465491A1 (en) * | 2001-11-07 | 2003-05-15 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
WO2003043995A1 (en) * | 2001-11-20 | 2003-05-30 | Cytokinetics, Inc. | Process for the racemization of chiral quinazolinones |
JP2005529076A (ja) * | 2002-02-15 | 2005-09-29 | サイトキネティクス・インコーポレーテッド | キナゾリノンの合成 |
MXPA04011074A (es) * | 2002-05-09 | 2005-06-08 | Cytokinetics Inc | Compuestos de pirimidinona, composiciones y metodos. |
AU2003270015A1 (en) | 2002-05-09 | 2003-12-02 | Cytokinetics, Inc. | Compounds, compositions, and methods |
EP1513820A4 (en) * | 2002-05-23 | 2006-09-13 | Cytokinetics Inc | COMPOUNDS, COMPOSITIONS AND METHODS |
AU2003236527A1 (en) * | 2002-06-14 | 2003-12-31 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US7211580B2 (en) * | 2002-07-23 | 2007-05-01 | Cytokinetics, Incorporated | Compounds, compositions, and methods |
JP2005536553A (ja) * | 2002-08-21 | 2005-12-02 | サイトキネティクス・インコーポレーテッド | 化合物、組成物および方法 |
WO2004034972A2 (en) * | 2002-09-30 | 2004-04-29 | Cytokinetics, Inc. | Compounds, compositions, and methods |
US7550590B2 (en) | 2003-03-25 | 2009-06-23 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
ZA200602051B (en) | 2003-08-13 | 2007-10-31 | Takeda Pharmaceutical | 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
WO2005016348A1 (en) * | 2003-08-14 | 2005-02-24 | Icos Corporation | Method of inhibiting immune responses stimulated by an endogenous factor |
US20050054614A1 (en) * | 2003-08-14 | 2005-03-10 | Diacovo Thomas G. | Methods of inhibiting leukocyte accumulation |
WO2005026148A1 (en) * | 2003-09-08 | 2005-03-24 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
JP2007513058A (ja) * | 2003-09-08 | 2007-05-24 | 武田薬品工業株式会社 | ジペプチジルぺプチダーゼ阻害剤 |
US20050197327A1 (en) * | 2003-11-03 | 2005-09-08 | Gustave Bergnes | Compounds, compositions, and methods |
US20050148593A1 (en) * | 2003-11-07 | 2005-07-07 | Gustave Bergnes | Compounds, compositions, and methods |
US7439254B2 (en) * | 2003-12-08 | 2008-10-21 | Cytokinetics, Inc. | Compounds, compositions, and methods |
CN102127053A (zh) * | 2004-03-15 | 2011-07-20 | 武田药品工业株式会社 | 二肽基肽酶抑制剂 |
HUE030950T2 (en) | 2004-05-13 | 2017-06-28 | Icos Corp | Quinazolinones as 3-kinase delta inhibitors of human phosphatidylinositol |
CA2567883A1 (en) * | 2004-05-25 | 2005-12-15 | Icos Corporation | Methods for treating and/or preventing aberrant proliferation of hematopoietic cells |
US7872124B2 (en) | 2004-12-21 | 2011-01-18 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
WO2006089106A2 (en) * | 2005-02-17 | 2006-08-24 | Icos Corporation | Phosphoinositide 3-kinase inhibitors for inhibiting leukocyte accumulation |
DE102005024017A1 (de) * | 2005-05-25 | 2006-11-30 | Merck Patent Gmbh | Chinazolinone |
WO2007033265A1 (en) * | 2005-09-14 | 2007-03-22 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors for treating diabetis |
DK1942898T4 (da) | 2005-09-14 | 2014-06-02 | Takeda Pharmaceutical | Dipeptidylpeptidase-inhibitorer til behandling af diabetes |
KR101368988B1 (ko) * | 2005-09-16 | 2014-02-28 | 다케다 야쿠힌 고교 가부시키가이샤 | 디펩티딜 펩티다제 억제제 |
JP2009531456A (ja) * | 2006-03-28 | 2009-09-03 | 武田薬品工業株式会社 | (r)−3−アミノピペリジン二塩酸塩の調製 |
EP2233472B1 (en) * | 2006-03-28 | 2014-01-15 | Atir Holding S.A. | Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
PE20081150A1 (es) * | 2006-09-13 | 2008-10-03 | Takeda Pharmaceutical | Inhibidores de dipetidilpeptidasa |
US8324383B2 (en) | 2006-09-13 | 2012-12-04 | Takeda Pharmaceutical Company Limited | Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile |
TW200838536A (en) * | 2006-11-29 | 2008-10-01 | Takeda Pharmaceutical | Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor |
US8093236B2 (en) | 2007-03-13 | 2012-01-10 | Takeda Pharmaceuticals Company Limited | Weekly administration of dipeptidyl peptidase inhibitors |
US9492449B2 (en) | 2008-11-13 | 2016-11-15 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
CA3092449A1 (en) | 2008-11-13 | 2010-05-20 | Gilead Calistoga Llc | Therapies for hematologic malignancies |
EP2411391A1 (en) | 2009-03-24 | 2012-02-01 | Gilead Calistoga LLC | Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
ES2548253T3 (es) * | 2009-04-20 | 2015-10-15 | Gilead Calistoga Llc | Métodos para el tratamiento de tumores sólidos |
MX2012000817A (es) | 2009-07-21 | 2012-05-08 | Gilead Calistoga Llc | Tratamiento para desordenes del higado con inhibidores pi3k. |
US9353067B2 (en) | 2011-04-10 | 2016-05-31 | Atir Holding S.A. | Heterocyclic compounds and uses thereof in the treatment of sexual disorders |
PE20141792A1 (es) | 2012-03-05 | 2014-12-07 | Gilead Calistoga Llc | Formas polimorficas de (s)-2-(1-(9h-purin-6-ilamino)propil)-5-fluor-3-fenilquinazolin-4(3h)-ona |
EP3083623A1 (en) | 2013-12-20 | 2016-10-26 | Gilead Calistoga LLC | Polymorphic forms of a hydrochloride salt of (s) -2-(9h-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3h) -one |
CA2934531C (en) | 2013-12-20 | 2020-02-25 | Gilead Calistoga Llc | Process methods for phosphatidylinositol 3-kinase inhibitors |
CN106459005A (zh) | 2014-06-13 | 2017-02-22 | 吉利德科学公司 | 磷脂酰肌醇3‑激酶抑制剂 |
-
0
- DE DENDAT1249281D patent/DE1249281B/de active Pending
- GB GB1053063D patent/GB1053063A/en active Active
-
1963
- 1963-05-18 DE DEF39784A patent/DE1231705B/de active Pending
-
1964
- 1964-05-14 US US367568A patent/US3322756A/en not_active Expired - Lifetime
- 1964-05-14 CH CH90567A patent/CH447183A/de unknown
- 1964-05-14 SE SE5933/64A patent/SE314074B/xx unknown
- 1964-05-14 CH CH628164A patent/CH447181A/de unknown
- 1964-05-14 CH CH90467A patent/CH447182A/de unknown
- 1964-05-15 AT AT774665A patent/AT258918B/de active
- 1964-05-15 NL NL6405448A patent/NL6405448A/xx unknown
- 1964-05-15 AT AT774565A patent/AT258917B/de active
- 1964-05-15 DK DK245564AA patent/DK104409C/da active
- 1964-05-15 DK DK531164AA patent/DK106039C/da active
- 1964-05-15 DK DK531064AA patent/DK105765C/da active
- 1964-05-15 AT AT427764A patent/AT254193B/de active
- 1964-05-19 BE BE648093A patent/BE648093A/xx unknown
- 1964-08-17 FR FR985329A patent/FR3806M/fr active Active
-
1965
- 1965-11-23 SE SE1512665A patent/SE314076B/xx unknown
- 1965-11-23 SE SE1512565A patent/SE314075B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
SE314075B (US20040242566A1-20041202-C00134.png) | 1969-09-01 |
AT258917B (de) | 1967-12-27 |
CH447182A (de) | 1967-11-30 |
GB1053063A (US20040242566A1-20041202-C00134.png) | |
DK104409C (da) | 1966-05-16 |
DK105765C (da) | 1966-11-07 |
NL6405448A (US20040242566A1-20041202-C00134.png) | 1964-11-19 |
FR3806M (fr) | 1966-01-03 |
DE1231705B (de) | 1967-01-05 |
AT258918B (de) | 1967-12-27 |
DE1249281B (US20040242566A1-20041202-C00134.png) | |
BE648093A (US20040242566A1-20041202-C00134.png) | 1964-11-19 |
SE314074B (US20040242566A1-20041202-C00134.png) | 1969-09-01 |
AT254193B (de) | 1967-05-10 |
DK106039C (da) | 1966-12-12 |
SE314076B (US20040242566A1-20041202-C00134.png) | 1969-09-01 |
US3322756A (en) | 1967-05-30 |
CH447181A (de) | 1967-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AT258918B (de) | Verfahren zur Herstellung von neuen Chinazolon-Verbindungen | |
AT253687B (de) | Verfahren zur Herstellung von neuen Benzomorphanen | |
CH482648A (de) | Verfahren zur Herstellung von neuen Phenylzyklopropanverbindungen | |
AT250942B (de) | Verfahren zur Herstellung von neuen Sulfonamiden | |
CH443330A (de) | Verfahren zur Herstellung von neuen Benzomorphane | |
CH438319A (de) | Verfahren zur Herstellung von neuen Azepinderivaten | |
CH430733A (de) | Verfahren zur Herstellung von neuen Chinazolinon-Derivaten | |
AT304077B (de) | Verfahren zur Herstellung von neuen Esterimidharzen | |
CH441335A (de) | Verfahren zur Herstellung von Chinazolin-Derivaten | |
AT267747B (de) | Verfahren zur Herstellung von neuen Penicillanylalkoholen | |
AT248426B (de) | Verfahren zur Herstellung von neuen Imidazolderivaten | |
AT249068B (de) | Verfahren zur Herstellung von neuen Imidazo- und Pyrimido-chinazolinen | |
AT254184B (de) | Verfahren zur Herstellung von neuen Äthanoanthracenderivaten | |
AT242130B (de) | Verfahren zur Herstellung von neuen Nitrofuryl-Derivaten | |
AT251591B (de) | Verfahren zur Herstellung von neuen 4-Nitro-5-hydroxy-pyridazonen-(6) | |
AT251872B (de) | Verfahren zur Herstellung von neuen Copolymeren | |
AT257656B (de) | Verfahren zur Herstellung von neuen Organophosphoverbindungen | |
AT241431B (de) | Verfahren zur Herstellung von neuen Asparaginderivaten | |
CH419150A (de) | Verfahren zur Herstellung von neuen Imidazolderivaten | |
CH490335A (de) | Verfahren zur Herstellung von neuen Phenylzyklopropanverbindungen | |
AT270899B (de) | Verfahren zur Herstellung von neuen Xanthenen | |
CH429735A (de) | Verfahren zur Herstellung von neuen Azepinderivaten | |
CH416643A (de) | Verfahren zur Herstellung von neuen Azepinderivaten | |
AT249366B (de) | Verfahren zur Herstellung von neuen Telomerisaten | |
AT262504B (de) | Verfahren zur Herstellung von neuen Penicillinen |